A 4-Year Surveillance of Device-associated Nosocomial Infections in a Neonatal Intensive Care Unit

Basit Öğe Kaydı
dc.contributor.authorTekin, Recep
dc.contributor.authorDal, Tuba
dc.contributor.authorPirinccioglu, Habibe
dc.contributor.authorOygucu, Seyhan Erisir
dc.date.accessioned2024-04-24T16:15:47Z
dc.date.available2024-04-24T16:15:47Z
dc.date.issued2013
dc.departmentDicle Üniversitesien_US
dc.description.abstractBackground: The aim of this study was to determine the rate of health care-associated infection (HC-AI) and device-associated health care-associated infections (DA-HAIs), and distribution of causative microorganisms and etiologic factors responsible for these infections in a neonatal intensive care unit (NICU) of a state hospital in southeastern Turkey. Methods: A laboratory-based, active, prospective nosocomial infection surveillance study was performed in NICUs from January 2008 to December 2011. The rates of HC-AIs were determined on a daily basis. The findings were evaluated by applying the definitions of the Centers for Disease Control and Prevention National Healthcare Safety Network. Results: In a 4-year period, 580 HC-AIs, 81 of which were DA-HAIs, were detected among 6932 patients. The rate of hospital acquired infection was 8.3% and 7.69/1000 patient days. Ventilator-associated pneumonia (YAP) was the second most frequent (13.1%) HC-AI and the most frequent was DA-HAI. The VAP rate was 6A per 1000 ventilator days. Mechanical ventilation was the most frequently used invasive device. Median time to diagnosis of VAP was 32.11 +/- 29.3 days from the time of admission. Acinetobacter baumannii (48%) and Pseudomonas aeruginosa (32%) were the most frequent microorganisms. Colistin was the most effective antibiotic by in vitro test. The antibiotic resistance ratios of A. baumannii were >= 54% for carbapenems, aminoglycosides, and cefoperazone-sulbactam; >= 88% for quinolones; and >= 92% for ceftazidime, ceftriaxone, and piperacillin-tazobactam. Conclusions: Device-associated nosocomial infections was a particularly important problem in NICU. Close monitoring will decrease the rates of device-related nosocomial infections. Copyright (C) 2013, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights reserved.en_US
dc.identifier.doi10.1016/j.pedneo.2013.03.011
dc.identifier.endpage308en_US
dc.identifier.issn1875-9572
dc.identifier.issn2212-1692
dc.identifier.issue5en_US
dc.identifier.pmid23643153
dc.identifier.scopus2-s2.0-84889101209
dc.identifier.scopusqualityQ2
dc.identifier.startpage303en_US
dc.identifier.urihttps://doi.org/10.1016/j.pedneo.2013.03.011
dc.identifier.urihttps://hdl.handle.net/11468/15926
dc.identifier.volume54en_US
dc.identifier.wosWOS:000326215500005
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherElsevier Taiwanen_US
dc.relation.ispartofPediatrics and Neonatology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectDevice-Associated Health Care-Associated Infectionen_US
dc.subjectNeonatal Intensive Care Uniten_US
dc.subjectNosocomial Infectionen_US
dc.subjectVentilator-Associated Pneumoniaen_US
dc.titleA 4-Year Surveillance of Device-associated Nosocomial Infections in a Neonatal Intensive Care Uniten_US
dc.titleA 4-Year Surveillance of Device-associated Nosocomial Infections in a Neonatal Intensive Care Unit
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu